CompletedNot applicableNCT00822107
A Translational Approach to Gitelman Syndrome
Studying Gitelman syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oregon Health and Science University
- Principal Investigator
- David H Ellison, MDOregon Health and Science University
- Intervention
- Hydrochlorothiazide(drug)
- Enrollment
- 8 enrolled
- Eligibility
- 21-65 years · All sexes
- Timeline
- 2009 – 2013
Study locations (1)
- Oregon Health & Science University, Portland, Oregon, United States
Collaborators
Oregon Clinical and Translational Research Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00822107 on ClinicalTrials.govOther trials for Gitelman syndrome
Additional recruiting or active studies for the same condition.